News | July 08, 2021
RDIF and Morepen announce production of test batch of Sputnik V
The first batch will be shipped to the Gamaleya Center for the quality control
The first batch will be shipped to the Gamaleya Center for the quality control
The INVANZ brand and generic market had U.S. sales of approximately US $205 million MAT for the most recent twelve months ending March 2021 according to IQVIA Health
Market penetration of Sputnik V will depend on competitive pricing, government orders and the ability to meet soaring demand through timely supply
Subscribe To Our Newsletter & Stay Updated
